Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2013

Jan 4, 2013

31802_dirs_2013-01-04_badf1573-8bd6-4a9a-a84e-a5ed2ad3f1af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-12-27

Reporting Person: Kennedy Patricia J (VP, GM, International)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-27 Common Stock A 15000 $0.00 Acquired 31270 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-27 Stock Option (right to buy) $6.73 A 60000 Acquired 2022-12-27 Common Stock (60000) Direct

Footnotes

F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2005 Equity Incentive Plan. The shares will vest 25% annually over four years from date of grant.

F2: The option vests and is exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

F3: Not applicable